Covid antiviral drug launched in India
Covid antiviral drug Molnupiravir was launched in India, today at Rs 1,399 for a five-day course for mild to moderate infection.
New covid variant Omicron in the country, an expert panel of the Central Drugs Standard Control Organisation had approved antiviral drug Molnupiravir for restricted use in emergency situation.
CDSCO has also granted emergency use authorisation to the Serum Institute of India’s Covid vaccine COVOVAX, Hyderabad based Biological E RBD Protein CORBEVAX.